Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC. -- Ignore unavailable to you. Want to Upgrade?

To: Epics who wrote (152)	12/31/1998 10:45:00 AM
From: Lighthouse	Read Replies (1) \| Respond to of 211

Still here. All is quite on the Legal Front, but the sparks should begin to fly with the upcoming trial. Last I heard it was scheduled for January. This in my mind is the biggie. With GDT stock at $110 per share and GSI with such a big cash position, if I were GDT I would just purchase these guys and move on. The folks in Indy are big believers in EVA, well this would be very EVA positive. The last paragraph is the authors own (misguided?) opinion. Also expecting takeovers or other biz combinations is a bit like waiting for Godot. I want these guys to start gaining some serious traction (qtr run rate above $5 million), but my expectation is that for this to happen in the near term we have to get a positive ruling from the trial. And so we wait and wait and wait and wait.